Production at three Patheon plants affected by Hurricane Matthew

Sometimes drug manufacturers have to weather the storm, literally. CDMO Patheon reopened its Greenville, NC, site this weekend after temporarily closing it and two others that were in the path of Hurricane Matthew.

Company spokeswoman Mari Mansfield said on Monday that the Greenville plant “resumed full operations” on Saturday. 

In a filing Friday, Amsterdam-based Patheon said it had also temporarily stopped production at its plants in Florence, SC, and Manati, Puerto Rico, because of the weather and power outages. In Puerto Rico, a fire at a power plant had affected its facility in Manati. The Florence plant was also affected by a power outage. In Greenville, roadways were flooded and the company closed the facility to assure employee safety, it reported.

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

The manufacturer said none of the facilities was damaged. The company will update investors in early November about the impact on its fourth quarter but said it didn’t expect any effect on its 2017 financials.

In a note to investors, Evercore ISI analyst Ross Muken said the firm figured the plant closures could have a $5 million to $15 million revenue impact on the quarter. “Our revenue impact is based on the assumption that the facilities were closed for ~5 days on average and the three facilities account for ~25% of total manufacturing capacity,” he told investors.

Other drugmakers have faced disaster-related plant closures in the last couple of years. India’s Natco had to close a plant in Manali, near Chennai, last December because of flooding. The facility was later cited in a Form 483 by the FDA. In August 2015, GlaxoSmithKline closed a plant in China that was damaged by a huge explosion that ripped through the port there after a storage warehouse full of chemicals ignited. That plant closure led to some shortages in some markets.  

- here’s the 8-K

Related Articles: 
Natco plant closed during floods written up by FDA
GSK runs into supply issues after China plant damaged by nearby explosion


Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.